Michael Zuscik
Concepts (535)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoarthritis | 25 | 2025 | 180 | 5.770 |
Why?
| Chondrocytes | 45 | 2021 | 203 | 3.850 |
Why?
| Cartilage, Articular | 18 | 2021 | 297 | 2.300 |
Why?
| Transforming Growth Factor beta | 23 | 2014 | 462 | 1.840 |
Why?
| Chondrogenesis | 10 | 2016 | 82 | 1.330 |
Why?
| Gastrointestinal Microbiome | 3 | 2025 | 637 | 1.300 |
Why?
| Fracture Healing | 6 | 2014 | 78 | 1.180 |
Why?
| Menisci, Tibial | 3 | 2021 | 58 | 1.160 |
Why?
| Cell Differentiation | 33 | 2018 | 1858 | 1.120 |
Why?
| Joints | 3 | 2025 | 97 | 1.090 |
Why?
| Osteoarthritis, Knee | 6 | 2023 | 233 | 1.050 |
Why?
| Bone Morphogenetic Proteins | 15 | 2008 | 131 | 0.990 |
Why?
| Growth Plate | 8 | 2013 | 36 | 0.960 |
Why?
| Cartilage | 12 | 2021 | 182 | 0.850 |
Why?
| Lead | 6 | 2014 | 55 | 0.840 |
Why?
| Animals | 101 | 2025 | 34733 | 0.830 |
Why?
| Mice | 65 | 2021 | 16585 | 0.830 |
Why?
| Obesity | 10 | 2018 | 2851 | 0.780 |
Why?
| Disease Models, Animal | 18 | 2021 | 4016 | 0.780 |
Why?
| Osteogenesis | 13 | 2018 | 191 | 0.770 |
Why?
| Receptors, Adrenergic, alpha-1 | 8 | 2003 | 44 | 0.730 |
Why?
| Dysbiosis | 2 | 2020 | 166 | 0.730 |
Why?
| Joint Diseases | 1 | 2021 | 60 | 0.720 |
Why?
| Diet, High-Fat | 6 | 2018 | 241 | 0.710 |
Why?
| Knee Injuries | 2 | 2021 | 98 | 0.690 |
Why?
| Inflammation | 5 | 2020 | 2705 | 0.690 |
Why?
| Signal Transduction | 34 | 2021 | 4863 | 0.680 |
Why?
| Mice, Inbred C57BL | 26 | 2019 | 5279 | 0.660 |
Why?
| Smad3 Protein | 6 | 2012 | 44 | 0.660 |
Why?
| Wounds and Injuries | 3 | 2019 | 808 | 0.650 |
Why?
| beta Catenin | 11 | 2016 | 221 | 0.640 |
Why?
| Collagen Type I | 2 | 2017 | 115 | 0.560 |
Why?
| Dietary Supplements | 2 | 2021 | 534 | 0.550 |
Why?
| Microbiota | 1 | 2025 | 727 | 0.550 |
Why?
| Cells, Cultured | 31 | 2018 | 4058 | 0.530 |
Why?
| Bony Callus | 3 | 2014 | 7 | 0.510 |
Why?
| Bone Morphogenetic Protein 2 | 15 | 2014 | 76 | 0.500 |
Why?
| Diabetes Mellitus, Type 2 | 8 | 2018 | 2424 | 0.490 |
Why?
| Core Binding Factor Alpha 1 Subunit | 8 | 2019 | 44 | 0.480 |
Why?
| Teriparatide | 2 | 2011 | 6 | 0.470 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 6 | 2009 | 134 | 0.440 |
Why?
| NF-kappa B | 5 | 2021 | 687 | 0.440 |
Why?
| Dinoprostone | 5 | 2009 | 188 | 0.430 |
Why?
| Erythropoietin | 2 | 2017 | 89 | 0.410 |
Why?
| Neuroprotective Agents | 2 | 2016 | 110 | 0.410 |
Why?
| Osteoclasts | 7 | 2015 | 37 | 0.400 |
Why?
| Collagen Type X | 11 | 2012 | 13 | 0.400 |
Why?
| Receptors, Notch | 4 | 2015 | 85 | 0.400 |
Why?
| Receptors, Aryl Hydrocarbon | 2 | 2012 | 52 | 0.400 |
Why?
| Benzo(a)pyrene | 1 | 2012 | 7 | 0.400 |
Why?
| Staphylococcal Infections | 4 | 2018 | 385 | 0.400 |
Why?
| Trans-Activators | 11 | 2005 | 387 | 0.390 |
Why?
| X-Ray Microtomography | 9 | 2016 | 86 | 0.390 |
Why?
| Hindlimb | 2 | 2011 | 126 | 0.390 |
Why?
| Gene Expression Regulation | 15 | 2017 | 2522 | 0.390 |
Why?
| Collateral Ligaments | 1 | 2011 | 18 | 0.380 |
Why?
| Chickens | 13 | 2012 | 187 | 0.380 |
Why?
| Knee Joint | 4 | 2021 | 366 | 0.370 |
Why?
| Disease Progression | 9 | 2021 | 2612 | 0.350 |
Why?
| Ubiquitin-Protein Ligases | 6 | 2010 | 155 | 0.340 |
Why?
| Receptors, Adrenergic | 2 | 2000 | 35 | 0.330 |
Why?
| Regeneration | 1 | 2011 | 177 | 0.330 |
Why?
| Sciatic Nerve | 2 | 2017 | 59 | 0.330 |
Why?
| Sciatic Neuropathy | 3 | 2019 | 23 | 0.330 |
Why?
| Gene Library | 2 | 2000 | 119 | 0.330 |
Why?
| Parathyroid Hormone | 3 | 2013 | 100 | 0.320 |
Why?
| Chick Embryo | 11 | 2012 | 130 | 0.320 |
Why?
| Adiposity | 1 | 2014 | 507 | 0.320 |
Why?
| Mice, Transgenic | 19 | 2015 | 2075 | 0.310 |
Why?
| Tobacco Smoke Pollution | 1 | 2012 | 233 | 0.310 |
Why?
| Transcription Factor AP-1 | 3 | 2007 | 86 | 0.310 |
Why?
| Proto-Oncogene Proteins | 1 | 2012 | 636 | 0.310 |
Why?
| Cell Cycle Proteins | 4 | 2014 | 577 | 0.300 |
Why?
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 3 | 2013 | 6 | 0.300 |
Why?
| 4-Aminopyridine | 2 | 2019 | 23 | 0.300 |
Why?
| Potassium Channel Blockers | 2 | 2019 | 35 | 0.290 |
Why?
| Osteoblasts | 7 | 2015 | 118 | 0.290 |
Why?
| Bone and Bones | 6 | 2015 | 297 | 0.290 |
Why?
| Regenerative Medicine | 2 | 2022 | 45 | 0.280 |
Why?
| Receptors, Prostaglandin E | 3 | 2009 | 6 | 0.280 |
Why?
| Promoter Regions, Genetic | 8 | 2013 | 1195 | 0.260 |
Why?
| Lymphatic Vessels | 2 | 2019 | 59 | 0.260 |
Why?
| Parathyroid Hormone-Related Protein | 7 | 2005 | 24 | 0.250 |
Why?
| Gene Expression Regulation, Developmental | 9 | 2015 | 819 | 0.250 |
Why?
| Sulfonamides | 2 | 2002 | 494 | 0.240 |
Why?
| Severity of Illness Index | 3 | 2017 | 2783 | 0.240 |
Why?
| Neovascularization, Physiologic | 4 | 2014 | 179 | 0.240 |
Why?
| Meniscus | 2 | 2023 | 22 | 0.240 |
Why?
| Up-Regulation | 6 | 2017 | 850 | 0.240 |
Why?
| Calcium | 7 | 2002 | 1182 | 0.240 |
Why?
| Proteins | 4 | 2003 | 948 | 0.230 |
Why?
| Bone Development | 4 | 2011 | 48 | 0.230 |
Why?
| Phosphatidylinositols | 2 | 1994 | 57 | 0.230 |
Why?
| GTPase-Activating Proteins | 3 | 2014 | 82 | 0.230 |
Why?
| Transcription Factors | 7 | 2008 | 1636 | 0.220 |
Why?
| Limb Buds | 5 | 2010 | 22 | 0.220 |
Why?
| Ligases | 1 | 2003 | 31 | 0.220 |
Why?
| Synovial Membrane | 3 | 2019 | 85 | 0.210 |
Why?
| Calcium Signaling | 2 | 2002 | 236 | 0.210 |
Why?
| Cardiomegaly | 2 | 2003 | 172 | 0.210 |
Why?
| Arthritis, Experimental | 2 | 2015 | 128 | 0.210 |
Why?
| Azacitidine | 1 | 2004 | 138 | 0.210 |
Why?
| Smad Proteins | 6 | 2014 | 38 | 0.210 |
Why?
| Peptide Hormones | 1 | 2002 | 11 | 0.200 |
Why?
| Egtazic Acid | 1 | 2002 | 42 | 0.200 |
Why?
| Wnt Proteins | 4 | 2014 | 127 | 0.200 |
Why?
| DNA-Binding Proteins | 7 | 2004 | 1423 | 0.200 |
Why?
| Neurodegenerative Diseases | 2 | 2002 | 107 | 0.200 |
Why?
| Apoptosis | 6 | 2016 | 2485 | 0.200 |
Why?
| Intracellular Fluid | 1 | 2002 | 27 | 0.200 |
Why?
| Scleroderma, Systemic | 1 | 2003 | 109 | 0.200 |
Why?
| Macrophages | 3 | 2019 | 1459 | 0.200 |
Why?
| Cyclic AMP Response Element-Binding Protein | 5 | 2007 | 138 | 0.200 |
Why?
| Tibial Fractures | 2 | 2014 | 73 | 0.200 |
Why?
| Femur | 3 | 2013 | 242 | 0.190 |
Why?
| Proteoglycans | 4 | 2013 | 108 | 0.190 |
Why?
| Humans | 32 | 2025 | 129705 | 0.190 |
Why?
| Musculoskeletal System | 1 | 2022 | 46 | 0.190 |
Why?
| Male | 21 | 2019 | 63544 | 0.190 |
Why?
| Intercellular Signaling Peptides and Proteins | 4 | 2014 | 377 | 0.190 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2023 | 141 | 0.180 |
Why?
| SOX9 Transcription Factor | 2 | 2013 | 25 | 0.180 |
Why?
| Bone Remodeling | 4 | 2014 | 71 | 0.180 |
Why?
| Tissue Engineering | 3 | 2022 | 390 | 0.180 |
Why?
| Calcium Phosphates | 2 | 2010 | 23 | 0.180 |
Why?
| Femoral Fractures | 2 | 2012 | 74 | 0.180 |
Why?
| Matrix Metalloproteinase 13 | 4 | 2019 | 23 | 0.180 |
Why?
| Atrophy | 1 | 2000 | 165 | 0.170 |
Why?
| Cyclic AMP | 5 | 2005 | 231 | 0.170 |
Why?
| Smad1 Protein | 2 | 2011 | 19 | 0.170 |
Why?
| Bone Density | 3 | 2015 | 470 | 0.170 |
Why?
| Cyclin D1 | 2 | 2012 | 64 | 0.160 |
Why?
| Hypotension | 1 | 2001 | 124 | 0.160 |
Why?
| Epoetin Alfa | 1 | 2019 | 6 | 0.160 |
Why?
| Staphylococcus aureus | 3 | 2018 | 429 | 0.160 |
Why?
| Collagen | 1 | 2021 | 433 | 0.160 |
Why?
| Hematinics | 1 | 2019 | 19 | 0.160 |
Why?
| Nerve Compression Syndromes | 1 | 2019 | 24 | 0.160 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2023 | 271 | 0.160 |
Why?
| Recovery of Function | 2 | 2017 | 643 | 0.160 |
Why?
| Bortezomib | 1 | 2019 | 44 | 0.160 |
Why?
| Proteasome Inhibitors | 1 | 2019 | 44 | 0.160 |
Why?
| Body Weight | 5 | 2014 | 935 | 0.150 |
Why?
| Bifidobacterium longum | 1 | 2018 | 5 | 0.150 |
Why?
| Alkaline Phosphatase | 7 | 2011 | 148 | 0.150 |
Why?
| Tissue Scaffolds | 2 | 2010 | 193 | 0.150 |
Why?
| Bone Resorption | 3 | 2015 | 77 | 0.150 |
Why?
| Organ Size | 2 | 2014 | 448 | 0.150 |
Why?
| Germinal Center | 1 | 2018 | 54 | 0.150 |
Why?
| Osteomyelitis | 2 | 2017 | 122 | 0.150 |
Why?
| Immunity, Humoral | 2 | 2018 | 121 | 0.150 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 1998 | 45 | 0.150 |
Why?
| Oligosaccharides | 1 | 2018 | 57 | 0.150 |
Why?
| Osteolysis | 1 | 2018 | 17 | 0.150 |
Why?
| Aging | 3 | 2019 | 1769 | 0.140 |
Why?
| Coagulase | 1 | 2017 | 6 | 0.140 |
Why?
| RANK Ligand | 4 | 2015 | 26 | 0.140 |
Why?
| Foot | 1 | 2018 | 125 | 0.140 |
Why?
| Transforming Growth Factor beta1 | 4 | 2014 | 162 | 0.140 |
Why?
| Prosthesis-Related Infections | 1 | 2018 | 80 | 0.140 |
Why?
| Polymerase Chain Reaction | 1 | 2000 | 1047 | 0.130 |
Why?
| Hydrolysis | 1 | 2017 | 191 | 0.130 |
Why?
| Hedgehog Proteins | 5 | 2004 | 187 | 0.130 |
Why?
| Peripheral Nerve Injuries | 1 | 2016 | 35 | 0.130 |
Why?
| PPAR gamma | 2 | 2015 | 182 | 0.130 |
Why?
| Calcium Channels | 1 | 1997 | 149 | 0.130 |
Why?
| Cysteine-Rich Protein 61 | 1 | 2016 | 5 | 0.130 |
Why?
| Activating Transcription Factor 2 | 3 | 2013 | 5 | 0.130 |
Why?
| Glucose Intolerance | 2 | 2015 | 142 | 0.130 |
Why?
| Rotator Cuff Injuries | 1 | 2016 | 56 | 0.130 |
Why?
| Osteosarcoma | 2 | 2008 | 75 | 0.130 |
Why?
| Transcriptome | 2 | 2022 | 872 | 0.130 |
Why?
| Phenotype | 8 | 2019 | 3063 | 0.130 |
Why?
| Pain | 1 | 2021 | 770 | 0.120 |
Why?
| Gene Expression | 4 | 2014 | 1477 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2016 | 1208 | 0.120 |
Why?
| Receptor, Notch1 | 1 | 2015 | 62 | 0.120 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2010 | 962 | 0.120 |
Why?
| Mice, Knockout | 7 | 2014 | 2778 | 0.120 |
Why?
| Wound Healing | 2 | 2014 | 310 | 0.120 |
Why?
| Administration, Oral | 1 | 2017 | 790 | 0.120 |
Why?
| Bone Morphogenetic Protein 6 | 3 | 2004 | 3 | 0.120 |
Why?
| Osteocalcin | 2 | 2012 | 34 | 0.120 |
Why?
| Bone Regeneration | 1 | 2014 | 24 | 0.120 |
Why?
| Smad2 Protein | 2 | 2012 | 37 | 0.110 |
Why?
| Collagen Type II | 5 | 2013 | 47 | 0.110 |
Why?
| Bone Neoplasms | 2 | 2008 | 227 | 0.110 |
Why?
| Biomechanical Phenomena | 2 | 2014 | 783 | 0.110 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2015 | 170 | 0.110 |
Why?
| Bone Marrow | 1 | 2015 | 264 | 0.110 |
Why?
| Cell Division | 4 | 2004 | 802 | 0.110 |
Why?
| Glycogen Synthase Kinase 3 | 2 | 2014 | 78 | 0.110 |
Why?
| Endothelial Cells | 1 | 2019 | 736 | 0.110 |
Why?
| RNA, Messenger | 6 | 2008 | 2705 | 0.110 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2013 | 70 | 0.110 |
Why?
| Angiopoietin-2 | 1 | 2013 | 14 | 0.110 |
Why?
| Phosphoproteins | 2 | 2014 | 326 | 0.110 |
Why?
| Extracellular Matrix | 3 | 2013 | 493 | 0.100 |
Why?
| Tendon Injuries | 1 | 2014 | 83 | 0.100 |
Why?
| Fractures, Bone | 3 | 2014 | 421 | 0.100 |
Why?
| Animals, Newborn | 3 | 2019 | 819 | 0.100 |
Why?
| B-Lymphocytes | 1 | 2018 | 816 | 0.100 |
Why?
| Tretinoin | 2 | 2003 | 125 | 0.100 |
Why?
| RNA, Small Interfering | 2 | 2012 | 575 | 0.100 |
Why?
| Chelating Agents | 2 | 2002 | 68 | 0.100 |
Why?
| Intervertebral Disc Degeneration | 1 | 2012 | 31 | 0.100 |
Why?
| Intervertebral Disc Displacement | 1 | 2012 | 37 | 0.100 |
Why?
| Bone Transplantation | 1 | 2013 | 105 | 0.100 |
Why?
| Base Sequence | 6 | 2013 | 2161 | 0.100 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2011 | 3 | 0.100 |
Why?
| Anabolic Agents | 1 | 2011 | 12 | 0.100 |
Why?
| Serrate-Jagged Proteins | 1 | 2011 | 29 | 0.100 |
Why?
| Osteophyte | 1 | 2011 | 5 | 0.100 |
Why?
| Mast Cells | 1 | 2013 | 142 | 0.100 |
Why?
| Time Factors | 5 | 2014 | 6593 | 0.100 |
Why?
| Transcriptional Activation | 3 | 2017 | 360 | 0.090 |
Why?
| Mice, Inbred Strains | 2 | 2013 | 408 | 0.090 |
Why?
| Tibial Meniscus Injuries | 1 | 2011 | 45 | 0.090 |
Why?
| Arteries | 1 | 2013 | 268 | 0.090 |
Why?
| Orthopedic Procedures | 1 | 2014 | 228 | 0.090 |
Why?
| Neoplasm Proteins | 2 | 2004 | 429 | 0.090 |
Why?
| bcl-2-Associated X Protein | 2 | 2008 | 49 | 0.090 |
Why?
| Analysis of Variance | 2 | 2017 | 1288 | 0.090 |
Why?
| Cyclooxygenase 2 | 2 | 2009 | 172 | 0.090 |
Why?
| Bone Substitutes | 1 | 2010 | 27 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 3 | 2005 | 1969 | 0.090 |
Why?
| Histone Deacetylases | 1 | 2012 | 211 | 0.090 |
Why?
| RNA Interference | 1 | 2012 | 448 | 0.090 |
Why?
| RNA | 1 | 2016 | 877 | 0.090 |
Why?
| Calcium-Binding Proteins | 1 | 2011 | 213 | 0.090 |
Why?
| Rats | 9 | 2012 | 5244 | 0.080 |
Why?
| Cytoskeletal Proteins | 2 | 2007 | 141 | 0.080 |
Why?
| Dietary Fats | 1 | 2011 | 303 | 0.080 |
Why?
| Stress, Mechanical | 2 | 2010 | 470 | 0.080 |
Why?
| Osteoporosis | 1 | 2012 | 233 | 0.080 |
Why?
| Molecular Sequence Data | 5 | 2004 | 2848 | 0.080 |
Why?
| Isoquinolines | 2 | 2002 | 41 | 0.080 |
Why?
| Lactic Acid | 1 | 2010 | 299 | 0.080 |
Why?
| Blotting, Western | 5 | 2011 | 1189 | 0.080 |
Why?
| Nerve Crush | 1 | 2008 | 5 | 0.080 |
Why?
| Cell Survival | 1 | 2012 | 1083 | 0.080 |
Why?
| Inositol 1,4,5-Trisphosphate | 2 | 2001 | 30 | 0.070 |
Why?
| Weight Gain | 1 | 2011 | 505 | 0.070 |
Why?
| Neural Conduction | 2 | 2019 | 82 | 0.070 |
Why?
| Core Binding Factor Alpha 3 Subunit | 1 | 2007 | 6 | 0.070 |
Why?
| Female | 15 | 2019 | 68561 | 0.070 |
Why?
| Repressor Proteins | 2 | 2008 | 400 | 0.070 |
Why?
| Immunohistochemistry | 2 | 2010 | 1700 | 0.070 |
Why?
| High Mobility Group Proteins | 1 | 2007 | 42 | 0.070 |
Why?
| Protein Isoforms | 2 | 2007 | 369 | 0.070 |
Why?
| Tyrosine | 2 | 2010 | 219 | 0.070 |
Why?
| Ubiquitin | 2 | 2004 | 62 | 0.070 |
Why?
| Biocompatible Materials | 1 | 2010 | 394 | 0.070 |
Why?
| Polymers | 1 | 2010 | 475 | 0.070 |
Why?
| Cell Membrane | 3 | 2001 | 728 | 0.070 |
Why?
| Stem Cells | 3 | 2022 | 572 | 0.060 |
Why?
| Prazosin | 2 | 2002 | 27 | 0.060 |
Why?
| Cell Proliferation | 5 | 2013 | 2340 | 0.060 |
Why?
| Smad7 Protein | 1 | 2005 | 18 | 0.060 |
Why?
| I-kappa B Kinase | 2 | 2021 | 53 | 0.060 |
Why?
| Insulin | 1 | 2016 | 2313 | 0.060 |
Why?
| Enzyme Inhibitors | 3 | 2004 | 828 | 0.060 |
Why?
| Mutagenesis, Site-Directed | 3 | 2008 | 356 | 0.060 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 159 | 0.060 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 466 | 0.060 |
Why?
| Membrane Proteins | 1 | 2011 | 1108 | 0.060 |
Why?
| Radiation Tolerance | 1 | 2005 | 97 | 0.060 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 73 | 0.060 |
Why?
| Environmental Pollutants | 1 | 2007 | 142 | 0.060 |
Why?
| Adrenergic alpha-Antagonists | 2 | 2002 | 34 | 0.060 |
Why?
| Tibia | 2 | 2005 | 183 | 0.060 |
Why?
| Titanium | 1 | 2005 | 80 | 0.060 |
Why?
| Phenylalanine | 2 | 2001 | 60 | 0.060 |
Why?
| Activin Receptors, Type I | 1 | 2003 | 7 | 0.050 |
Why?
| Receptors, Growth Factor | 1 | 2003 | 55 | 0.050 |
Why?
| DNA Primers | 3 | 2013 | 523 | 0.050 |
Why?
| Mesoderm | 1 | 2004 | 139 | 0.050 |
Why?
| Phosphorylation | 4 | 2010 | 1687 | 0.050 |
Why?
| Cell Line | 3 | 2012 | 2768 | 0.050 |
Why?
| Protein Kinase C | 1 | 2004 | 259 | 0.050 |
Why?
| Cell Culture Techniques | 2 | 2022 | 355 | 0.050 |
Why?
| Transcription, Genetic | 5 | 2008 | 1409 | 0.050 |
Why?
| Bucladesine | 1 | 2002 | 24 | 0.050 |
Why?
| Annexin A5 | 1 | 2002 | 25 | 0.050 |
Why?
| Epinephrine | 2 | 2001 | 181 | 0.050 |
Why?
| Nitrates | 1 | 2002 | 87 | 0.050 |
Why?
| Peptide Library | 1 | 2002 | 87 | 0.050 |
Why?
| Carrier Proteins | 2 | 2005 | 730 | 0.050 |
Why?
| Hypertrophy | 1 | 2002 | 120 | 0.050 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1315 | 0.050 |
Why?
| Extracellular Space | 1 | 2002 | 124 | 0.050 |
Why?
| Gestational Age | 1 | 2005 | 857 | 0.050 |
Why?
| Dihydropyridines | 2 | 2001 | 15 | 0.050 |
Why?
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2001 | 19 | 0.050 |
Why?
| COS Cells | 2 | 2000 | 185 | 0.050 |
Why?
| Paroxetine | 1 | 2021 | 10 | 0.050 |
Why?
| Conserved Sequence | 2 | 2001 | 229 | 0.050 |
Why?
| Models, Animal | 2 | 2013 | 370 | 0.050 |
Why?
| G-Protein-Coupled Receptor Kinase 2 | 1 | 2021 | 11 | 0.050 |
Why?
| Heart Septum | 1 | 2001 | 28 | 0.050 |
Why?
| Phenylephrine | 1 | 2001 | 75 | 0.050 |
Why?
| Mole Rats | 1 | 2020 | 5 | 0.050 |
Why?
| Organ Culture Techniques | 1 | 2001 | 144 | 0.040 |
Why?
| Amino Acid Sequence | 3 | 2001 | 2051 | 0.040 |
Why?
| Substantia Nigra | 1 | 2000 | 51 | 0.040 |
Why?
| Bradycardia | 1 | 2001 | 57 | 0.040 |
Why?
| Adrenergic alpha-Agonists | 1 | 2000 | 30 | 0.040 |
Why?
| Complement Activation | 1 | 2023 | 359 | 0.040 |
Why?
| Cloning, Organism | 1 | 1999 | 7 | 0.040 |
Why?
| Blood Glucose | 3 | 2015 | 2090 | 0.040 |
Why?
| Imidazoles | 1 | 2001 | 224 | 0.040 |
Why?
| Norepinephrine | 1 | 2001 | 218 | 0.040 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1999 | 150 | 0.040 |
Why?
| Fibroblasts | 1 | 2005 | 946 | 0.040 |
Why?
| Transfection | 3 | 2009 | 904 | 0.040 |
Why?
| Spleen | 2 | 2015 | 520 | 0.040 |
Why?
| 3T3 Cells | 1 | 1999 | 151 | 0.040 |
Why?
| Solutions | 1 | 2000 | 147 | 0.040 |
Why?
| Femoral Artery | 1 | 2001 | 176 | 0.040 |
Why?
| Osteochondrodysplasias | 1 | 2019 | 15 | 0.040 |
Why?
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2019 | 6 | 0.040 |
Why?
| Genes, Reporter | 1 | 1999 | 269 | 0.040 |
Why?
| Lymphangiogenesis | 1 | 2019 | 25 | 0.040 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 395 | 0.040 |
Why?
| Models, Biological | 4 | 2010 | 1707 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2002 | 568 | 0.040 |
Why?
| Cloning, Molecular | 1 | 2000 | 536 | 0.040 |
Why?
| Gene Deletion | 2 | 2013 | 376 | 0.040 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2019 | 51 | 0.040 |
Why?
| Hydrocortisone | 1 | 2001 | 300 | 0.040 |
Why?
| Cell Hypoxia | 1 | 1999 | 238 | 0.040 |
Why?
| Immunoglobulin Class Switching | 1 | 2018 | 15 | 0.040 |
Why?
| Organ Specificity | 1 | 2019 | 296 | 0.040 |
Why?
| Epilepsy | 1 | 2002 | 314 | 0.040 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2010 | 7 | 0.040 |
Why?
| Decompression, Surgical | 1 | 2019 | 97 | 0.040 |
Why?
| Coculture Techniques | 1 | 2019 | 217 | 0.040 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3601 | 0.040 |
Why?
| Sodium-Hydrogen Exchangers | 1 | 1998 | 26 | 0.040 |
Why?
| Cytidine Deaminase | 1 | 2018 | 57 | 0.040 |
Why?
| Echocardiography | 1 | 2001 | 635 | 0.040 |
Why?
| Cytosol | 2 | 2005 | 212 | 0.040 |
Why?
| Isoproterenol | 1 | 1998 | 111 | 0.040 |
Why?
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2009 | 5 | 0.040 |
Why?
| Cerebral Cortex | 1 | 2000 | 407 | 0.040 |
Why?
| GTP-Binding Proteins | 1 | 1998 | 156 | 0.040 |
Why?
| Seizures | 1 | 2000 | 396 | 0.040 |
Why?
| Ion Transport | 1 | 1997 | 58 | 0.030 |
Why?
| Sequence Homology, Amino Acid | 1 | 1998 | 370 | 0.030 |
Why?
| Myelin P0 Protein | 1 | 2017 | 7 | 0.030 |
Why?
| Adrenergic beta-Agonists | 1 | 1998 | 132 | 0.030 |
Why?
| Intermediate Filaments | 1 | 2017 | 27 | 0.030 |
Why?
| Muscle, Smooth, Vascular | 1 | 1999 | 431 | 0.030 |
Why?
| Cadmium | 1 | 1997 | 67 | 0.030 |
Why?
| Potassium | 1 | 1997 | 140 | 0.030 |
Why?
| Calcium Channel Blockers | 1 | 1997 | 126 | 0.030 |
Why?
| Abscess | 1 | 2017 | 73 | 0.030 |
Why?
| Heart Rate | 1 | 2001 | 808 | 0.030 |
Why?
| Sternum | 2 | 2009 | 25 | 0.030 |
Why?
| Membrane Potentials | 1 | 1997 | 260 | 0.030 |
Why?
| Kinetics | 2 | 1998 | 1620 | 0.030 |
Why?
| Antibodies, Neutralizing | 1 | 2019 | 260 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 1 | 1998 | 544 | 0.030 |
Why?
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 267 | 0.030 |
Why?
| Microscopy, Electron | 1 | 2017 | 418 | 0.030 |
Why?
| Antibodies, Bacterial | 1 | 2017 | 145 | 0.030 |
Why?
| Fibrinogen | 1 | 2017 | 160 | 0.030 |
Why?
| In Vitro Techniques | 2 | 1995 | 1063 | 0.030 |
Why?
| Epiphyses | 1 | 2016 | 20 | 0.030 |
Why?
| Virulence | 1 | 2017 | 254 | 0.030 |
Why?
| Cell Separation | 2 | 2015 | 313 | 0.030 |
Why?
| Receptor, IGF Type 2 | 1 | 1995 | 7 | 0.030 |
Why?
| Caspase 3 | 2 | 2008 | 242 | 0.030 |
Why?
| Parkinson Disease | 1 | 2000 | 408 | 0.030 |
Why?
| DNA | 1 | 2002 | 1406 | 0.030 |
Why?
| Luciferases | 2 | 2005 | 148 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 2 | 2010 | 530 | 0.030 |
Why?
| Leukocyte Common Antigens | 1 | 2015 | 80 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 423 | 0.030 |
Why?
| Oximes | 1 | 2014 | 21 | 0.030 |
Why?
| Shoulder Joint | 1 | 2016 | 163 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2016 | 164 | 0.030 |
Why?
| Smad6 Protein | 2 | 2004 | 2 | 0.030 |
Why?
| Calcification, Physiologic | 2 | 2010 | 34 | 0.030 |
Why?
| Tumor Cells, Cultured | 2 | 2005 | 929 | 0.030 |
Why?
| Adaptive Immunity | 1 | 2015 | 164 | 0.030 |
Why?
| STAT3 Transcription Factor | 1 | 2015 | 187 | 0.030 |
Why?
| Blood Pressure | 1 | 2001 | 1747 | 0.030 |
Why?
| Kidney | 1 | 2001 | 1330 | 0.030 |
Why?
| In Situ Hybridization | 2 | 2004 | 295 | 0.030 |
Why?
| Adipocytes | 1 | 2015 | 204 | 0.030 |
Why?
| Recombinant Fusion Proteins | 2 | 2009 | 640 | 0.030 |
Why?
| Age Factors | 1 | 2000 | 3145 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 2 | 2003 | 55 | 0.030 |
Why?
| Protein Binding | 2 | 2013 | 2088 | 0.030 |
Why?
| Protein Structure, Tertiary | 1 | 2015 | 833 | 0.030 |
Why?
| Hydrodynamics | 1 | 2012 | 40 | 0.030 |
Why?
| ADAMTS5 Protein | 1 | 2012 | 5 | 0.030 |
Why?
| Bioreactors | 1 | 2012 | 49 | 0.030 |
Why?
| Toxicity Tests, Acute | 1 | 2012 | 9 | 0.030 |
Why?
| ADAM Proteins | 1 | 2012 | 59 | 0.020 |
Why?
| Glycoproteins | 1 | 2014 | 340 | 0.020 |
Why?
| Leptin | 1 | 2013 | 218 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2003 | 2039 | 0.020 |
Why?
| Fasting | 1 | 2013 | 266 | 0.020 |
Why?
| Transplantation, Homologous | 1 | 2013 | 404 | 0.020 |
Why?
| Mitochondria, Liver | 1 | 1991 | 73 | 0.020 |
Why?
| Indoles | 1 | 2014 | 379 | 0.020 |
Why?
| Cell Nucleus | 1 | 2014 | 570 | 0.020 |
Why?
| Flow Cytometry | 1 | 2015 | 1151 | 0.020 |
Why?
| Cell Surface Extensions | 1 | 2010 | 12 | 0.020 |
Why?
| Phospholipase C gamma | 1 | 2010 | 28 | 0.020 |
Why?
| Implants, Experimental | 1 | 2010 | 18 | 0.020 |
Why?
| Sodium | 1 | 1991 | 204 | 0.020 |
Why?
| Compressive Strength | 1 | 2010 | 71 | 0.020 |
Why?
| Porosity | 1 | 2010 | 92 | 0.020 |
Why?
| Gene Expression Profiling | 2 | 2011 | 1696 | 0.020 |
Why?
| Cell Line, Tumor | 2 | 2008 | 3106 | 0.020 |
Why?
| Transcription Factor HES-1 | 1 | 2010 | 4 | 0.020 |
Why?
| Polyesters | 1 | 2010 | 72 | 0.020 |
Why?
| Cricetinae | 2 | 2001 | 275 | 0.020 |
Why?
| Trabecular Meshwork | 1 | 2011 | 79 | 0.020 |
Why?
| Swine | 1 | 2012 | 744 | 0.020 |
Why?
| Fibrosis | 1 | 2013 | 521 | 0.020 |
Why?
| src-Family Kinases | 1 | 2010 | 94 | 0.020 |
Why?
| Homeostasis | 1 | 2013 | 604 | 0.020 |
Why?
| Surface Properties | 1 | 2010 | 391 | 0.020 |
Why?
| Structure-Activity Relationship | 2 | 2001 | 539 | 0.020 |
Why?
| Treatment Outcome | 2 | 2016 | 10299 | 0.020 |
Why?
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 63 | 0.020 |
Why?
| Materials Testing | 1 | 2010 | 343 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2010 | 403 | 0.020 |
Why?
| Biomarkers | 2 | 2015 | 3893 | 0.020 |
Why?
| Collagen Type IX | 1 | 2008 | 1 | 0.020 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 245 | 0.020 |
Why?
| Wings, Animal | 1 | 2008 | 41 | 0.020 |
Why?
| Tamoxifen | 1 | 2009 | 199 | 0.020 |
Why?
| Axin Protein | 1 | 2007 | 18 | 0.020 |
Why?
| Insulin Resistance | 1 | 2016 | 1165 | 0.020 |
Why?
| Response Elements | 1 | 2008 | 87 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2010 | 1241 | 0.020 |
Why?
| Cholecalciferol | 1 | 2008 | 59 | 0.020 |
Why?
| Combined Modality Therapy | 1 | 2010 | 1213 | 0.020 |
Why?
| Core Binding Factor Alpha 2 Subunit | 1 | 2007 | 32 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 1306 | 0.020 |
Why?
| Protein Transport | 1 | 2009 | 424 | 0.020 |
Why?
| Lead Poisoning | 1 | 2007 | 19 | 0.020 |
Why?
| Polycyclic Aromatic Hydrocarbons | 1 | 2007 | 25 | 0.020 |
Why?
| Metals, Heavy | 1 | 2007 | 28 | 0.020 |
Why?
| Vitamins | 1 | 2008 | 172 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2010 | 480 | 0.020 |
Why?
| Transducin | 1 | 2006 | 43 | 0.020 |
Why?
| Radiography | 1 | 2009 | 863 | 0.020 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2005 | 49 | 0.020 |
Why?
| Caspase 9 | 1 | 2005 | 54 | 0.020 |
Why?
| Cytochromes c | 1 | 2005 | 61 | 0.020 |
Why?
| Antigens, Differentiation | 1 | 2005 | 82 | 0.020 |
Why?
| Hydrogels | 1 | 2012 | 634 | 0.020 |
Why?
| TCF Transcription Factors | 1 | 2005 | 16 | 0.020 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2005 | 22 | 0.020 |
Why?
| I-kappa B Proteins | 1 | 2005 | 77 | 0.020 |
Why?
| Adenoviridae | 1 | 2006 | 195 | 0.020 |
Why?
| Joint Capsule | 1 | 2005 | 11 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2005 | 159 | 0.020 |
Why?
| Cartilage Diseases | 1 | 2005 | 39 | 0.020 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 43 | 0.010 |
Why?
| Collagenases | 1 | 2004 | 23 | 0.010 |
Why?
| Caspases | 1 | 2005 | 249 | 0.010 |
Why?
| Cell Count | 1 | 2005 | 317 | 0.010 |
Why?
| Aged, 80 and over | 1 | 2016 | 7074 | 0.010 |
Why?
| Bromodeoxyuridine | 1 | 2004 | 77 | 0.010 |
Why?
| Embryo, Mammalian | 1 | 2005 | 223 | 0.010 |
Why?
| Skull | 1 | 2005 | 128 | 0.010 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2004 | 174 | 0.010 |
Why?
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2003 | 10 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 82 | 0.010 |
Why?
| Receptor Cross-Talk | 1 | 2003 | 21 | 0.010 |
Why?
| Smad5 Protein | 1 | 2003 | 8 | 0.010 |
Why?
| Morphogenesis | 1 | 2004 | 159 | 0.010 |
Why?
| Genes, src | 1 | 2003 | 5 | 0.010 |
Why?
| Cytokine Receptor gp130 | 1 | 2003 | 10 | 0.010 |
Why?
| Mice, Inbred CBA | 1 | 2003 | 51 | 0.010 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 289 | 0.010 |
Why?
| DNA, Complementary | 1 | 2003 | 271 | 0.010 |
Why?
| Synucleins | 1 | 2002 | 7 | 0.010 |
Why?
| Eukaryotic Initiation Factor-3 | 1 | 2002 | 4 | 0.010 |
Why?
| Tartrate-Resistant Acid Phosphatase | 1 | 2002 | 4 | 0.010 |
Why?
| Bacteriophage T7 | 1 | 2002 | 5 | 0.010 |
Why?
| Multiple System Atrophy | 1 | 2002 | 6 | 0.010 |
Why?
| Acid Phosphatase | 1 | 2002 | 19 | 0.010 |
Why?
| Videotape Recording | 1 | 2002 | 32 | 0.010 |
Why?
| Inclusion Bodies | 1 | 2002 | 25 | 0.010 |
Why?
| Two-Hybrid System Techniques | 1 | 2002 | 56 | 0.010 |
Why?
| Smad4 Protein | 1 | 2002 | 36 | 0.010 |
Why?
| alpha-Synuclein | 1 | 2002 | 30 | 0.010 |
Why?
| Animals, Genetically Modified | 1 | 2003 | 232 | 0.010 |
Why?
| Drug Synergism | 1 | 2003 | 354 | 0.010 |
Why?
| Macromolecular Substances | 1 | 2002 | 212 | 0.010 |
Why?
| Cellular Senescence | 1 | 2003 | 176 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2003 | 311 | 0.010 |
Why?
| Down-Regulation | 1 | 2004 | 637 | 0.010 |
Why?
| Isoenzymes | 1 | 2002 | 304 | 0.010 |
Why?
| Oxymetazoline | 1 | 2001 | 2 | 0.010 |
Why?
| Dioxanes | 1 | 2001 | 7 | 0.010 |
Why?
| Clonidine | 1 | 2001 | 27 | 0.010 |
Why?
| Oligodendroglia | 1 | 2002 | 159 | 0.010 |
Why?
| Cerebellum | 1 | 2002 | 216 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 773 | 0.010 |
Why?
| Ephedrine | 1 | 2000 | 4 | 0.010 |
Why?
| Inositol Phosphates | 1 | 2000 | 22 | 0.010 |
Why?
| Antigens, CD | 1 | 2003 | 479 | 0.010 |
Why?
| Electroencephalography | 1 | 2002 | 387 | 0.010 |
Why?
| Protein Structure, Secondary | 1 | 2001 | 335 | 0.010 |
Why?
| Spinal Cord | 1 | 2002 | 362 | 0.010 |
Why?
| Sequence Alignment | 1 | 2000 | 333 | 0.010 |
Why?
| Protein-Tyrosine Kinases | 1 | 2003 | 421 | 0.010 |
Why?
| Piperazines | 1 | 2001 | 327 | 0.010 |
Why?
| Models, Chemical | 1 | 2000 | 263 | 0.010 |
Why?
| Survival Rate | 1 | 2002 | 1894 | 0.010 |
Why?
| Motor Activity | 1 | 2002 | 670 | 0.010 |
Why?
| Protein Conformation | 1 | 2000 | 852 | 0.010 |
Why?
| Aged | 1 | 2016 | 22113 | 0.010 |
Why?
| Models, Molecular | 1 | 2001 | 1480 | 0.010 |
Why?
| Stimulation, Chemical | 1 | 1995 | 62 | 0.010 |
Why?
| Blotting, Northern | 1 | 1995 | 202 | 0.010 |
Why?
| Middle Aged | 1 | 2016 | 31103 | 0.010 |
Why?
| Neurons | 1 | 2002 | 1428 | 0.010 |
Why?
| Calorimetry | 1 | 1991 | 66 | 0.010 |
Why?
| Pregnancy | 1 | 2004 | 6273 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1991 | 365 | 0.010 |
Why?
| Fura-2 | 1 | 1990 | 19 | 0.010 |
Why?
| Cell Fractionation | 1 | 1990 | 55 | 0.010 |
Why?
| Brain | 1 | 2002 | 2596 | 0.010 |
Why?
| Organelles | 1 | 1990 | 55 | 0.010 |
Why?
| Adult | 1 | 2008 | 35595 | 0.000 |
Why?
|
|
Zuscik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|